手稿标题:突尼斯针对性抗癌疗法的消费和支出趋势
Farah Allani1, Sarah Zerei1, Skander Daghfous2
1Ministry of health -Department: ANMPS. Tunisia; Faculty of Pharmacy, 5000 Monastir, Tunisia.
Journal of cancer policy
|February 20, 2026
概括
突尼斯面临着针对性抗癌治疗成本的挑战. 诸如药物经济评估和本地制造等策略是可持续获得这些重要癌症药物的关键.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 制药政策 制药政策
背景情况:
- 针对性的抗癌疗法改变了癌症护理,但在突尼斯增加了医疗保健成本.
- 分析国家消费和支出趋势对于管理这些财务负担至关重要.
研究的目的:
- 分析2010年至2021年突尼斯针对性抗癌疗法的消费和支出的国家趋势.
- 确定影响这些趋势的因素,并为可持续获取提供政策解决方案.
主要方法:
- 追溯分析国家数据 (2010-2021年).
- 评估支出,消费量,治疗类分布和市场授权状态.
主要成果:
- 消费量增加,支出增长88% (2010-2017年),主要是单克隆抗体.
- 尽管消费增加,但支出下降了15% (2017-2020年),单克隆抗体和氨酸激酶抑制剂之间的市场份额更为平衡.
- 趋势受到增加的市场授权,生物类似药/仿制药的吸收 (从2014年开始) 和当地制造业的影响.
结论:
- 突尼斯在平衡获得向抗癌疗法的机会与财务可持续性方面面临着挑战.
- 药物经济战略,持续评估,价格修订和促进本地制造对于可持续和公平的获取是必不可少的.
关键词:
生物类似药和仿制药药物 获取 药物 获取毒品消费 毒品消费 毒品消费 毒品消费支出 支出 支出 支出单克隆抗体是一种单克隆抗体.瘤学药物药物 在瘤学药物药物药物经济学 药物经济学针对性的抗癌疗法 针对性的抗癌疗法铁氨基激酶抑制剂 铁氨基激酶抑制剂更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.8K
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.6K
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Cancer
54.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.8K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
Therapeutic Drug Monitoring: Affecting Factors
266
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
266
